PICO Portalanswers from OpenAlex
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
PaperCitations, authors & open-access status
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma is a paper indexed in PICO Portal from OpenAlex.
How many citations does Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma have?
PICO Portalcitation count
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma has 532 citations in the OpenAlex counts PICO Portal stores.
When was Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma published?
PICO Portalyear
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma has 2022 year in the PICO Portal index.
What is the open-access status of Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma?
PICO Portaloa status
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma has green oa status in the PICO Portal index.
What is the OpenAlex record for Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma?
PICO Portalopenalex
The OpenAlex for Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma is on the source record.